Participant Database for Autism Research Studies

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2012 by Massachusetts General Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Martha Herbert, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00549731
First received: October 15, 2007
Last updated: May 31, 2013
Last verified: April 2012
  Purpose

The purpose of this study is to create a subject database to recruit for current and future studies in research on autism and other neurodevelopmental disabilities.


Condition
Autism Spectrum Disorder
Developmental Language Disorders

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Participant Database for Persons Interested in Autism Research Studies: Recruiting, Pre-Screening and Diagnostic Assessment

Resource links provided by NLM:


Further study details as provided by Massachusetts General Hospital:

Estimated Enrollment: 5000
Study Start Date: June 2005
Estimated Study Completion Date: January 2014
Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
Detailed Description:

Aim 1: to recruit people interested in research on autism and other neurodevelopmental disabilities

Aim 2: to complete a diagnostic assessment, to confirm the diagnosis of autism spectrum disorder or other developmental disability (e.g., developmental language delay) in our patient population and rule out a diagnosis of autism spectrum disorder and other comorbid conditions in our control group

Aim 3: to maintain subject information in a database, from which we can recruit for our studies

  Eligibility

Ages Eligible for Study:   up to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Adult/Pediatric

Criteria

Inclusion Criteria:

  • Enrollment will be open to typically-developing, healthy children and adults (ages 0-45), children and adults with autism spectrum disorder (ages 0-45), siblings of children and adults with autism spectrum disorder (ages 0-45), and children and adults with developmental language delays (ages 0-45).
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00549731

Contacts
Contact: Manuel Zetino, Rsch Coord 617-766-9766 TRANSCEND@partners.org

Locations
United States, Massachusetts
Martinos Center of Biomedical Imaging Recruiting
Charlestown, Massachusetts, United States, 02129
Sponsors and Collaborators
Massachusetts General Hospital
Investigators
Principal Investigator: Martha Herbert, MD, Ph.D Massachusetts General Hospital
Principal Investigator: Tal Kenet, Ph.D Massachusetts General Hospital
Principal Investigator: Katherine Martien, MD Massachusetts General Hospital/LADDERS
  More Information

No publications provided

Responsible Party: Martha Herbert, M.D., PhD, Massachusetts General Hospital
ClinicalTrials.gov Identifier: NCT00549731     History of Changes
Other Study ID Numbers: 2007-P-000062
Study First Received: October 15, 2007
Last Updated: May 31, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Massachusetts General Hospital:
autism
autistic
language
development
developmental
assessment

Additional relevant MeSH terms:
Language Disorders
Autistic Disorder
Child Development Disorders, Pervasive
Disease
Language Development Disorders
Communication Disorders
Mental Disorders
Mental Disorders Diagnosed in Childhood
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Pathologic Processes
Signs and Symptoms

ClinicalTrials.gov processed this record on October 30, 2014